Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
Clinical trial NCT00129896 · COMPLETED
Trial details
- NCT number
- NCT00129896
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.